Trexquant Investment’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-35,422
| Closed | -$961K | – | 1223 |
|
|
2019
Q2 | $961K | Buy |
35,422
+19,934
| +129% | +$541K | 0.09% | 327 |
|
|
2019
Q1 | $537K | Buy |
+15,488
| New | +$537K | 0.04% | 568 |
|
|
2018
Q4 | – | Sell |
-33,440
| Closed | -$891K | – | 1426 |
|
|
2018
Q3 | $891K | Buy |
+33,440
| New | +$891K | 0.07% | 387 |
|
|
2018
Q2 | – | Sell |
-14,756
| Closed | -$482K | – | 1375 |
|
|
2018
Q1 | $482K | Buy |
+14,756
| New | +$482K | 0.03% | 651 |
|
|
2017
Q4 | – | Sell |
-7,325
| Closed | -$396K | – | 1340 |
|
|
2017
Q3 | $396K | Sell |
7,325
-1,975
| -21% | -$107K | 0.1% | 356 |
|
|
2017
Q2 | $522K | Sell |
9,300
-18,321
| -66% | -$1.03M | 0.14% | 229 |
|
|
2017
Q1 | $1.08M | Buy |
+27,621
| New | +$1.08M | 0.14% | 220 |
|
|
2016
Q4 | – | Sell |
-30,682
| Closed | -$697K | – | 1212 |
|
|
2016
Q3 | $697K | Sell |
30,682
-20,493
| -40% | -$466K | 0.16% | 211 |
|
|
2016
Q2 | $1.21M | Buy |
51,175
+28,412
| +125% | +$671K | 0.16% | 184 |
|
|
2016
Q1 | $464K | Sell |
22,763
-38,537
| -63% | -$786K | 0.05% | 574 |
|
|
2015
Q4 | $3.15M | Buy |
+61,300
| New | +$3.15M | 0.28% | 67 |
|
|
2015
Q3 | – | Sell |
-17,900
| Closed | -$815K | – | 1360 |
|
|
2015
Q2 | $815K | Sell |
17,900
-8,400
| -32% | -$382K | 0.09% | 415 |
|
|
2015
Q1 | $998K | Buy |
+26,300
| New | +$998K | 0.1% | 368 |
|